Literature DB >> 18512846

A comparison of cardiac (31)P MRS at 1.5 and 3 T.

Damian J Tyler1, Lucy E Hudsmith, Kieran Clarke, Stefan Neubauer, Matthew D Robson.   

Abstract

(31)P MRS was evaluated on normal volunteers at 1.5 and 3 T, and the signal-to-noise ratio (SNR) of the two field strengths was calculated. The in vivo spin-lattice, T(1), relaxation times for PCr and gamma-ATP, which are essential for correcting for the effects of radiofrequency saturation on the PCr/ATP ratio, were determined at 3 T. The T(1) values for six volunteers were 3.8 +/- 0.7 s for PCr (mean +/- SD) and 2.4 +/- 1.1 s for gamma-ATP, which are similar to reported values at 1.5 T, allowing us to use protocols developed at 1.5 T at the new clinical field strength of 3 T. Direct comparison between 1.5 T and 3 T in the same 10 subjects, using coils of identical geometry and identical pulse sequences gave a mean SNR for PCr at 3 T which was 206 +/- 94% of that at 1.5 T. The linewidth for PCr increased from 13 +/- 6 Hz at 1.5 T to 22 +/- 12 Hz at 3 T. The coefficient of variation in the measurement of PCr/ATP, based on the Cramer-Rao lower bounds, was reduced from 32 +/- 25% at 1.5 T to 18 +/- 13% at 3 T. Thus, (31)P MRS at 3 T is greatly improved by the increase in SNR compared with acquisitions at 1.5 T because of the higher field strength. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18512846     DOI: 10.1002/nbm.1255

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  13 in total

Review 1.  Principals and clinical applications of magnetic resonance cardiac spectroscopy in heart failure.

Authors:  Waqas T Qureshi; Usama Bin Nasir
Journal:  Heart Fail Rev       Date:  2017-07       Impact factor: 4.214

2.  Triple repetition time saturation transfer (TRiST) 31P spectroscopy for measuring human creatine kinase reaction kinetics.

Authors:  Michael Schär; Abdel-Monem M El-Sharkawy; Robert G Weiss; Paul A Bottomley
Journal:  Magn Reson Med       Date:  2010-06       Impact factor: 4.668

3.  Clinical applications for cardiovascular magnetic resonance imaging at 3 tesla.

Authors:  Allison G Hays; Michael Schär; Sebastian Kelle
Journal:  Curr Cardiol Rev       Date:  2009-08

4.  Quantification of human high-energy phosphate metabolite concentrations at 3 T with partial volume and sensitivity corrections.

Authors:  Abdel-Monem M El-Sharkawy; Refaat E Gabr; Michael Schär; Robert G Weiss; Paul A Bottomley
Journal:  NMR Biomed       Date:  2013-06-03       Impact factor: 4.044

5.  Reproducibility of creatine kinase reaction kinetics in human heart: a (31) P time-dependent saturation transfer spectroscopy study.

Authors:  Adil Bashir; Robert Gropler
Journal:  NMR Biomed       Date:  2014-04-06       Impact factor: 4.044

6.  Left ventricular torsion, energetics, and diastolic function in normal human aging.

Authors:  Kieren G Hollingsworth; Andrew M Blamire; Bernard D Keavney; Guy A Macgowan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-16       Impact factor: 4.733

7.  Rapid quantification of myocardial lipid content in humans using single breath-hold 1H MRS at 3 Tesla.

Authors:  Belen Rial; Matthew D Robson; Stefan Neubauer; Jürgen E Schneider
Journal:  Magn Reson Med       Date:  2011-06-30       Impact factor: 4.668

Review 8.  Cardiovascular magnetic resonance at 3.0 T: current state of the art.

Authors:  John N Oshinski; Jana G Delfino; Puneet Sharma; Ahmed M Gharib; Roderic I Pettigrew
Journal:  J Cardiovasc Magn Reson       Date:  2010-10-07       Impact factor: 5.364

9.  Clinical protocols for ³¹P MRS of the brain and their use in evaluating optic pathway gliomas in children.

Authors:  Jan Novak; Martin Wilson; Lesley Macpherson; Theodoros N Arvanitis; Nigel P Davies; Andrew C Peet
Journal:  Eur J Radiol       Date:  2013-11-25       Impact factor: 3.528

Review 10.  Non-invasive investigation of myocardial energetics in cardiac disease using 31P magnetic resonance spectroscopy.

Authors:  Mark A Peterzan; Andrew J M Lewis; Stefan Neubauer; Oliver J Rider
Journal:  Cardiovasc Diagn Ther       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.